Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review

Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review

Among working-age people, diabetic retinopathy and diabetic macular edema are currently considered the main causes of blindness. Nowadays, intravitreal injections are widely acknowledged as a significant milestone in ophthalmology, especially for the treatment of several retinal diseases, including...

Full description

Bibliographic Details
Main Authors: Livio Vitiello, Giulio Salerno, Alessia Coppola, Ilaria De Pascale, Giulia Abbinante, Vincenzo Gagliardi, Filippo Lixi, Alfonso Pellegrino, Giuseppe Giannaccare
Format: Article
Language:English
Published: MDPI AG 2024-06-01
Series:Life
Subjects:
dexamethasone implant
diabetic macular edema
diabetic retinopathy
intravitreal injections
Online Access:https://www.mdpi.com/2075-1729/14/6/725

Internet

https://www.mdpi.com/2075-1729/14/6/725

Similar Items